ACT-709478: Clinical Trials

2 trials of ACT-709478, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2

Follow ACT-709478: new trials by email Literature Review of ACT-709478 trials Research Report on ACT-709478

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Compare a Single-dose of Two Different Formulations of ACT-709478 in Healthy Men
ACT-709478 - Healthy Subjects
Phase 1CompletedIdorsia Pharmaceuticals Ltd.202019-12-162020-02-25
Study to Evaluate Safety and Tolerability of ACT-709478 in Healthy Subjects
ACT-709478, Placebo, Midazolam - Healthy Subjects
Phase 1CompletedIdorsia Pharmaceuticals Ltd.462017-07-072019-12-24

Sponsors

Idorsia Pharmaceuticals Ltd. (2)

Countries

Czechia (1)  ·  Germany (1)

Results publications

PMID 31994022

NIH funding

2017 (1), 2019 (1)